| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |